User contributions
- 23:34, 21 November 2024 diff hist +6,707 N Dahlgaarddall2509 Created page with "n-based neoadjuvant anti-HER2 therapy may be applied as an optimal treatment duration for screening high-risk HER2-positive breast cancer patients for escalation treatment. Fu..." current